Photocatalytic degradation of antibiotic sulfamethizole by visible light activated perovskite LaZnO3
Journal of Environmental Sciences · 2024-10 · 144 · 212-224
DOI: 10.1016/j.jes.2023.08.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Environmental Sciences, 2024-10. Verfasst von Bui The Huy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Major of Biomedical Engineering, Division of Smart Healthcare, College of Information Technology and Convergence, Pukyong National University, Busan …. Hauptthemen laut MEDLINE: Light, Anti-Bacterial Agents, Titanium, Oxides. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 73 Literaturangaben.
Abstract (Originalsprache)
In this work, the perovskite LaZnO3 was synthesized via sol-gel method and applied for photocatalytic treatment of sulfamethizole (SMZ) antibiotics under visible light activation. SMZ was almost completely degraded (99.2% ± 0.3%) within 4 hr by photocatalyst LaZnO3 at the optimal dosage of 1.1 g/L, with a mineralization proportion of 58.7% ± 0.4%. The efficient performance of LaZnO3 can be attributed to its wide-range light absorption and the appropriate energy band edge levels, which facilitate the formation of active agents such as ·O2-, h+, and ·OH. The integration of RP-HPLC/Q-TOF-MS and DFT-based computational techniques revealed three degradation pathways of SMZ, which were initiated by the deamination reaction at the aniline ring, the breakdown of the sulfonamide moieties, and a process known as Smile-type rearrangement and SO2 intrusion. Corresponding toxicity of SMZ and the intermediates were analyzed by quantitative structure activity relationship (QSAR), indicating the effectiveness of LaZnO3-based photocatalysis in preventing secondary pollution of the intermediates to the ecosystem during the degradation process. The visible-light-activated photocatalyst LaZnO3 exhibited efficient performance in the occurrence of inorganic anions and maintained high durability across multiple recycling tests, making it a promising candidate for practical antibiotic treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Major of Biomedical Engineering, Division of Smart Healthcare, College of Information Technology and Convergence, Pukyong National University, Busan 48513, Korea.
- Center for Advanced Chemistry, Institute of Research and Development, Duy Tan University, Da Nang 550000, Viet Nam; Faculty of Environmental and Chemical Engineering, Duy Tan University, Da Nang 550000, Viet Nam.
- Department of Environment and Energy, Sejong University, Seoul 05006, Korea.
- Lab of Computational Chemistry and Modelling, Department of Chemistry, Faculty of Natural Sciences, Quy Nhon University, Quy Nhon, Viet Nam.
- Department of Nanotechnology and Advanced Materials Engineering, Sejong University, Seoul 05006, Korea.
- Faculty of Materials Science and Technology, University of Science, Ho Chi Minh City 700000, Viet Nam; Vietnam National University, Ho Chi Minh City 700000, Viet Nam.
Zitieren
APA
Huy, B. T., Nguyen, X. C., Bui, V. K. H., Tri, N. N., Rabani, I., Tran, N. H. T., Ly, Q. V., & Truong, H. B. (2024). Photocatalytic degradation of antibiotic sulfamethizole by visible light activated perovskite LaZnO3. Journal of Environmental Sciences, 144, 212-224. https://doi.org/10.1016/j.jes.2023.08.004
Vancouver
Huy BT, Nguyen XC, Bui VKH, Tri NN, Rabani I, Tran NHT, et al. Photocatalytic degradation of antibiotic sulfamethizole by visible light activated perovskite LaZnO3. Journal of Environmental Sciences. 2024;144:212-224. doi:10.1016/j.jes.2023.08.004
BibTeX
@article{Huy2024,
author = {Huy, Bui The and Nguyen, X Cuong and Bui, Vu Khac Hoang and Tri, Nguyen Ngoc and Rabani, Iqra and Tran, Nhu Hoa Thi and Ly, Quang Viet and Truong, Hai Bang},
title = {Photocatalytic degradation of antibiotic sulfamethizole by visible light activated perovskite LaZnO3},
journal = {Journal of Environmental Sciences},
year = {2024},
volume = {144},
pages = {212--224},
doi = {10.1016/j.jes.2023.08.004}
}
EUVIMED